Coronavirus: who's at increased risk & features of survivors VS non-survivors
In this three part video series, we that dive deeper into some of these details:
-What is the ACE2 receptor and why it’s relevant to the Coronavirus conversation.
-Reviewing the features of hospitalized patients and non-severe VS severe patients
-Are there commonalties amongst non-survivors?
We address this and much more—included some of the references you may find helpful.
Coronavirus & ACE2: why Men, Diabetics May Be at Higher Risk
Immune support strategies: science review
References:
1. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. Journal of Thoracic Oncology. February 2020:1-18. doi:10.1016/j.jtho.2020.02.010.
2. Chen J. Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation. Preprints. March 2020:1-15.
3. MD ZX, MD LS, PhD YW, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory. February 2020:1-3. doi:10.1016/S2213-2600(20)30076-X.
4. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. February 2020:1-30. doi:10.1101/2020.02.06.20020974.
0 comments